Guillaume Leurent
Overview
Explore the profile of Guillaume Leurent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
959
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leurent G, LOfficial G, Anselmi A, Donal E, Auffret V
EuroIntervention
. 2025 Mar;
21(5):e285-e286.
PMID: 40028732
No abstract available.
2.
Nolf M, Boulmier D, Leurent G, Tomasi J, Le Bars F, Bakhti A, et al.
Arch Cardiovasc Dis
. 2025 Feb;
PMID: 39924380
Background: Transcatheter aortic valve implantation may be associated with significant haemorrhagic complications. Aims: To evaluate the timing, incidence, predictors and clinical impact of bleeding events after transcatheter aortic valve implantation,...
3.
Donal E, Dreyfus J, Leurent G, Coisne A, Leroux P, Ganivet A, et al.
JAMA
. 2024 Nov;
333(2):124-132.
PMID: 39602173
Importance: Correction of tricuspid regurgitation using tricuspid transcatheter edge-to-edge repair (T-TEER) in addition to guideline-directed optimized medical therapy (OMT) may improve clinical outcomes. Objective: To evaluate the efficacy of T-TEER ...
4.
Volle K, Merdji H, Bataille V, Lamblin N, Roubille F, Levy B, et al.
Clin Res Cardiol
. 2024 Oct;
PMID: 39441346
Background: Despite scarce data, invasive mechanical ventilation (MV) is widely suggested as first-line ventilatory support in cardiogenic shock (CS) patients. We assessed the real-life use of different ventilation strategies in...
5.
Stolz L, Cheung A, Boone R, Fam N, Ong G, Villablanca P, et al.
JACC Cardiovasc Interv
. 2024 Aug;
17(16):1936-1945.
PMID: 39197992
Background: Data on procedural and early outcomes after transjugular transcatheter tricuspid valve replacement (TTVR) are limited. Objectives: This study sought to evaluate first-in-man procedural and clinical outcomes after transjugular TTVR...
6.
Cherbi M, Merdji H, Labbe V, Bonnefoy E, Lamblin N, Roubille F, et al.
Arch Cardiovasc Dis
. 2024 Jul;
117(8-9):470-479.
PMID: 39048471
Background: Cardiogenic shock and sepsis are severe haemodynamic states that are frequently present concomitantly, leading to substantial mortality. Despite its frequency and clinical significance, there is a striking lack of...
7.
The admission level of CRP during cardiogenic shock is a strong independent risk marker of mortality
Roubille F, Cherbi M, Kalmanovich E, Delbaere Q, Bonnefoy-Cudraz E, Puymirat E, et al.
Sci Rep
. 2024 Jul;
14(1):16338.
PMID: 39014136
Inflammatory processes are involved not only in coronary artery disease but also in heart failure (HF). Cardiogenic shock (CS) and septic shock are classically distinct although intricate relationships are frequent...
8.
Curtis E, Lemarchand L, Lee K, Galli E, LOfficial G, Auffret V, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Jul;
25(12):1734-1742.
PMID: 39012790
Aims: Assessing right heart function is challenging, particularly when significant tricuspid regurgitation (TR) is present. Amongst available echocardiographic techniques for assessment, literatures suggest that strain imaging may be more reliable...
9.
Donal E, Gegout L, Leurent G, Lee K
JACC Cardiovasc Interv
. 2024 Apr;
17(7):904-906.
PMID: 38599693
No abstract available.
10.
Cherbi M, Bonnefoy E, Puymirat E, Lamblin N, Gerbaud E, Bonello L, et al.
Arch Cardiovasc Dis
. 2024 Apr;
117(4):255-265.
PMID: 38594150
Background: Chronic kidney disease (CKD) is one of the leading causes of death worldwide, closely interrelated with cardiovascular diseases, ultimately leading to the failure of both organs - the so-called...